VON WILLEBRAND FACTOR ANTIGEN IN BLOOD PLASMA OF PATIENTS WITH URINARY BLADDER CARCINOMA

By Zietek Z.   Iwan-Zietek I.   Paczulski R.   Kotschy M.   Wolski Z.  

Thrombosis Research, Vol. 83, Iss. 5, 1996-09 ,pp. : 399-402

Elsevier

Access to resources Recommend Favorite

The Effect of Polyclonal Antibody against Fibronectin on von Willebrand Factor Multimeric Size - Physiology and Pharmacology

By Kempfer A.C.   Faras C.E.   Carballo G.A.   Silaf M.R.   Lazzari M.A.  

Thrombosis Research, Vol. 96, Iss. 2, 1999-10 ,pp. : 161-167

Elsevier

Access to resources Recommend Favorite

Proteolysis of Subendothelial Adhesive Glycoproteins (Fibronectin, Thrombospondin, and von Willebrand Factor) by Plasmin, Leukocyte Cathepsin G, and Elastase

By Bonnefoy A.   Legrand C.  

Thrombosis Research, Vol. 98, Iss. 4, 2000-05 ,pp. : 323-332

Elsevier

Access to resources Recommend Favorite

Adjuvant Effect of Antibodies against von Willebrand Factor, Fibrinogen, and Fibronectin on Staphylokinase-Induced Thrombolysis as Measured Using Mural Thrombi Formed in Rat Mesenteric Venules

By Yamamoto J.   Kawano M.   Hashimoto M.   Sasaki Y.   Yamashita T.   Taka T.   Watanabe S.   Giddings J.C.  

Thrombosis Research, Vol. 97, Iss. 5, 2000-03 ,pp. : 327-333

Elsevier

Access to resources Recommend Favorite

A comparison of von Willebrand Factor antigen with platelet activity in vitro in normal and venous occlusion blood

By O'Brien John R.   Tsai Han-Mou   Etherington Michael D.  

Platelets, Vol. 12, Iss. 1, 2001-02 ,pp. : 27-33

Informa Healthcare

Access to resources Recommend Favorite